Symmetric dimethylarginine alters endothelial nitric oxide activity in glomerular endothelial cells

Denis Feliers, Duck Yoon Lee, Yves Gorin, Balakuntalam S. Kasinath

Research output: Contribution to journalArticlepeer-review

18 Scopus citations


Circulating symmetric dimethylarginine (SDMA) is increased in patients with chronic kidney disease. SDMA is considered an inert metabolite, but because it can transported into cells, we studied the effect of SDMA on glomerular endothelial cells. SDMA suppressed VEGF-induced endothelial nitric oxide synthase (eNOS) phosphorylation and nitric oxide production, but not VEGFR2 activation and signaling leading to eNOS activation. SDMA caused eNOS uncoupling and increased superoxide anion production in response to VEGF. All these effects were blocked by preventing cellular uptake of SDMA with a molar excess of arginine. These data show that SDMA interferes with nitric oxide production by uncoupling eNOS and leads to oxidative stress in glomerular endothelial cells.In conclusion, our data show that SDMA is not an inert metabolite and that it could contribute to oxidative stress in the renal endothelium.

Original languageEnglish (US)
Pages (from-to)1-5
Number of pages5
JournalCellular Signalling
Issue number1
StatePublished - Jan 1 2015


  • Glomerular endothelial cells
  • Kidney
  • Nitric oxide
  • Oxidative stress
  • Symmetric dimethylarginine

ASJC Scopus subject areas

  • Cell Biology


Dive into the research topics of 'Symmetric dimethylarginine alters endothelial nitric oxide activity in glomerular endothelial cells'. Together they form a unique fingerprint.

Cite this